|
| Group I Control group (n = 25) | Group II Study group (n = 25) | X2 | P value |
| Recurrence |
| |||
| Yes | 4 (16.0%) | 0 (0.0%) | 4.348 | 0.037* |
| No | 21 (84.0%) | 25 (100.0%) | 5.430 | 0.062 |
| Pregnancy rate in infertility cases | 4/7 (57.1%) | 6/6 (100.0% | 3.342 | 0.067 |
| Complications |
| |||
| Dull aching pain | 7/25 (28%) | 6/25 (24%) | 0.103 | 0.747 |
| Cyst rupture | 1/25 (4%) | 2/25 (8%) | 0.352 | 0.552 |
| Dizziness | 3/25 (12%) | 1/25 (4%) | 1.093 | 0.297 |
| Nausea/vomiting | 3/25 (12%) | 1/25 (4%) | 1.093 | 0.297 |
| Methotrexate leakage | NA | 2/25 (8%) | NA | NA |
| Hypersensitivity to Methotrexate | NA | 0/25 (0%) | NA | NA |